Breast cancer: An overview of published Indian data

 

PDF Download Permissions and Reprints

Abstract

The Incidence of breast cancer has been steadily increasing in the last two decades, more so in urban areas of the sub-continent. Cancer ceters across the country have large numbers of patients being treated with multiple publications in this field. Inspite of paucity of prospective data and randomised clinical trials from India, there are large number of retrospective publications on various aspects of the disease including pathology, radiology, surgery, chemotherapy, radiation, palliative care and alternatitive treatment modalities. These published data provide an insight into the trends of breast cancer in the country and this comprehensive data review of Indian data will provide a basis for designing trials relevant to our population and planning health care.

Publication History

Article published online:
28 December 2020

© 2016. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

• References

• 1 Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
• 2 Asthana S, Chauhan S, Labani S. Breast and cervical cancer risk in India: An update. Indian J Public Health 2014;58:5-10.
• 3 Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, et al. Cancer mortality in India: A nationally representative survey. Lancet 2012;379:1807-16.
• 4 Khokhar A. Breast cancer in India: Where do we stand and where do we go? Asian Pac J Cancer Prev 2012;13:4861-6.
• 5 Shet T, Chinoy RF, Members of Bombay Breast group. Spectrum of breast Pathology - A Project across 10 Institutes in Mumbai. Conference proceedings Third Update of Breast Diseases; 1998. p. 52-60.
• 6 Shet T. Time to change the way we diagnose mucinous carcinomas of the breast. Hum Pathol 2014;45:434-5.
• 7 Shet T, Agrawal A, Nadkarni M, Palkar M, Havaldar R, Parmar V, et al. Hormone receptors over the last 8 years in a cancer referral center in India: What was and what is? Indian J Pathol Microbiol 2009;52:171-4.
• 8 Mane A, Khatib KI, Deshmukh SP, Nag SM, Sane SP, Zade BP. A comparison of clinical features, pathology and outcomes in various subtypes of breast cancer in Indian women. J Clin Diagn Res 2015;9:PC01-4.
• 9 Kumar N, Patni P, Agarwal A, Khan MA, Parashar N. Prevalence of molecular subtypes of invasive breast cancer: A retrospective study. Med J Armed Forces India 2015;71:254-8.
• 10 Dogra A, Doval DC, Sardana M, Chedi SK, Mehta A. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India. Asian Pac J Cancer Prev 2014;15:10577-83.
• 11 Patnayak R, Jena A, Rukmangadha N, Chowhan AK, Sambasivaiah K, Phaneendra BV, et al. Hormone receptor status (estrogen receptor, progesterone receptor), human epidermal growth factor-2 and p53 in South Indian breast cancer patients: A tertiary care center experience. Indian J Med Paediatr Oncol 2015;36:117-22.
• 12 Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.N Engl J Med 1989;320:822-8.
• 13 Dinshaw KA, Sarin R, Budrukkar AN, Shrivastava SK, Deshpande DD, Chinoy RF, et al. Safety and feasibility of breast conserving therapy in Indian women: Two decades of experience at Tata Memorial Hospital. J Surg Oncol 2006;94:105-13.
• 14 Parmar V, Nadkarni MS, Kakade A, Hawaldar R, Badwe RA. Does the patient′s opinion differ from the clinicians′ regarding breast cosmesis after BCT? Breast J 2010;16:103-4.
• 15 Pandey M, Thomas BC, Ramdas K, Ratheesan K. Early effect of surgery on quality of life in women with operable breast cancer. Jpn J Clin Oncol 2006;36:468-72.
• 16 Nadkarni MS, Gupta PB, Parmar VV, Badwe RA. Breast conservation surgery without pre-operative mammography - A definite feasibility. Breast 2006;15:595-600.
• 17 Thorat MA, Rangole A, Nadkarni MS, Parmar V, Badwe RA. Revision surgery for breast cancer: Single-institution experience. Cancer 2008 15;113 8 Suppl: 2347-52.
• 18 Tewari M, Kumar K, Kumar M, Shukla HS. Residual breast tissue in the skin flaps after Patey mastectomy. Indian J Med Res 2004;119:195-7.
• 19 Badwe R, Hawaldar R, Parmar V, Nadkarni M, Shet T, Desai S, et al. Single-injection depot progesterone before surgery and survival in women with operable breast cancer: A randomized controlled trial. J Clin Oncol 2011;29:2845-51.
• 20 Adimulam G, Challa VR, Dhar A, Chumber S, Seenu V, Srivastava A. Assessment of cosmetic outcome of oncoplastic breast conservation surgery in women with early breast cancer: A prospective cohort study. Indian J Cancer 2014;51:58-62.
• 21 Sharma MM, Chauhan A. Oncoplastic breast surgery: Initial experience in an Oncology Center. Med J Armed Forces India 2014;70:175-8.
• 22 Sarkar DK, Maji A, Saha S, Biswas JK. Oncoplastic breast surgery-Our Experiences in the breast clinic, IPGME and R, Kolkata. Indian J Surg Oncol 2011;2:112-7.
• 23 Parmar V, Krishnamurthy A, Hawaldar R, Nadkarni MS, Sarin R, Chinoy R, et al. Breast conservation treatment in women with locally advanced breast cancer - Experience from a single centre. Int J Surg 2006;4:106-14.
• 24 Nadkarni MS, Raina S, Badwe RA. Medial pectoral pedicle: A critical landmark in axillary dissection. ANZ J Surg 2006;76:652-4.
• 25 Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: What we have learned in the last two decades. J Breast Cancer 2012;15:373-80.
• 26 Nadkarni MS, Rangole AK, Sharma RK, Hawaldar RV, Parmar VV, Badwe RA. Influence of surgical technique on axillary seroma formation: A randomized study. ANZ J Surg 2007;77:385-9.
• 27 Kottayasamy Seenivasagam R, Gupta V, Singh G. Prevention of seroma formation after axillary dissection - A comparative randomized clinical trial of three methods. Breast J 2013;19:478-84.
• 28 Parmar V, Hawaldar R, Nair NS, Shet T, Vanmali V, Desai S, et al. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer. Breast 2013;22:1081-6.
• 29 Chintamani, Tandon M, Mishra A, Agarwal U, Saxena S. Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - A prospective study. World J Surg Oncol 2011;9:19.
• 30 Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: An open-label randomised controlled trial. Lancet Oncol 2015;16:1380-8.
• 31 Narayanan SS, Goel V, Sarin R, Jalali R, Shrivastava SK, Deshpande DD, et al. Intraoperative high-dose-rate 192Ir radical implant in early breast cancer: A quality assurance and dosimetry study. Int J Radiat Oncol Biol Phys 2003;56:690-6.
• 32 Sharma SD, Budrukkar A, Upreti RR, Munshi A, Jalali R, Deshpande DD. Dosimetric comparison of conventional radiograph- and three-dimensional computed tomography-based planning using dose volume indices for partial breast intraoperative implants. Clin Oncol (R Coll Radiol) 2008;20:46-52.
• 33 Wadasadawala T, Sarin R, Budrukkar A, Jalali R, Munshi A, Badwe R. Accelerated partial-breast irradiation vs conventional whole-breast radiotherapy in early breast cancer: A case-control study of disease control, cosmesis, and complications. J Cancer Res Ther 2009;5:93-101.
• 34 Wadasadawala T, Budrukkar A, Chopra S, Badwe R, Hawaldar R, Parmar V, et al. Quality of life after accelerated partial breast irradiation in early breast cancer: Matched pair analysis with protracted whole breast radiotherapy. Clin Oncol (R Coll Radiol) 2009;21:668-75.
• 35 Budrukkar A, Jagtap V, Kembhavi S, Munshi A, Jalali R, Seth T, et al. Fat necrosis in women with early-stage breast cancer treated with accelerated partial breast irradiation (APBI) using interstitial brachytherapy. Radiother Oncol 2012;103:161-5.
• 36 Budrukkar A, Gurram L, Upreti RR, Munshi A, Jalali R, Badwe R, et al. Clinical outcomes of prospectively treated 140 women with early stage breast cancer using accelerated partial breast irradiation with 3 dimensional computerized tomography based brachytherapy. Radiother Oncol 2015;115:349-54.
• 37 Yadav BS, Sharma SC, Singh R, Singh G, Kumar V. Postmastectomy radiation and survival in patients with breast cancer. J Cancer Res Ther 2007;3:218-24.
• 38 Yadav BS, Sharma SC, George P, Bansal A. Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: Is there a benefit? J Cancer Res Ther 2014;10:279-83.
• 39 Nandi M, Mahata A, Mallick I, Achari R, Chatterjee S. Hypofractionated radiotherapy for breast cancers - Preliminary results from a tertiary care center in eastern India. Asian Pac J Cancer Prev 2014;15:2505-10.
• 40 Deore SM, Sarin R, Dinshaw KA, Shrivastava SK. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: Analysis of 289 cases. Int J Radiat Oncol Biol Phys 1993;26:601-6.
• 41 Sarin R, Dinshaw KA, Shrivastava SK, Sharma V, Deore SM. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys 1993;27:285-92.
• 42 Budrukkar AN, Sarin R, Shrivastava SK, Deshpande DD, Dinshaw KA. Cosmesis, late sequelae and local control after breast-conserving therapy: Influence of type of tumour bed boost and adjuvant chemotherapy. Clin Oncol (R Coll Radiol) 2007;19:596-603.
• 43 Jalali R, Malde R, Bhutani R, Budrukkar A, Badwe R, Sarin R. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy. Breast 2008;17:64-70.
• 44 Srinivas SK, Reddy KS, Vivekanandam S, Parthasarathy V. Role of template guided interstitial implants in breast conservation therapy. J Cancer Res Ther 2005;1:79-83.
• 45 Dutta S, Sharma SC, Singh R, Kapoor R, Oinam AS, Bhardwaj A, et al. Quality assessment of interstitial implants in high- dose- rate brachytherapy after lumpectomy in patients of early stage breast cancer. Indian J Surg Oncol 2010;1:294-302.
• 46 Rajan SS, Sharma SC, Kumar N, Kumar R, Singh G, Singh R, et al. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: A randomized study between electron and photon. J Cancer Res Ther 2014;10:889-95.
• 47 Gupta D, Raina V, Rath GK, Shukla NK, Mohanti BK, Sharma DN. Clinical and pathological response rates of docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer and comparison with anthracycline-based chemotherapies: Eight-year experience from single centre. Indian J Cancer 2011;48:410-4.
• 48 Gupta S, Bharath R, Shet T, Desai SB, Patil VM, Bakshi A, et al. Single agent weekly paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: A feasibility study. Clin Oncol (R Coll Radiol) 2012;24:604-9.
• 49 Mukherjee P, Sharma S, Sheikh ZA, Vijaykumar DK. Correlation of clinico-pathologic and radiologic parameters of response to neoadjuvant chemotherapy in breast cancer. Indian J Cancer 2014;51:25-9.
• 50 Raina V, Kunjahari M, Shukla NK, Deo SV, Sharma A, Mohanti BK, et al. Outcome of combined modality treatment including neoadjuvant chemotherapy of 128 cases of locally advanced breast cancer: Data from a tertiary cancer center in Northern India. Indian J Cancer 2011;48:80-5.
• 51 Roy C, Choudhury KB, Pal M, Saha A, Bag S, Banerjee C. Adjuvant chemotherapy with six cycles of AC regimen versus three cycles of AC regimen followed by three cycles of Paclitaxel in node-positive breast cancer. Indian J Cancer 2012;49:266-71.
• 52 Palappallil DS, Nair BL, Jayakumar KL, Puvathalil RT. Comparative study of the toxicity of 5-fluorouracil-adriamycin-cyclophosphamide versus adriamycin-cyclophosphamide followed by paclitaxel in carcinoma breast. Indian J Cancer 2011;48:68-73.
• 53 Shanta V, Swaminathan R, Rama R, Radhika R. Retrospective analysis of locally advanced noninflammatory breast cancer from Chennai, South India, 1990-1999. Int J Radiat Oncol Biol Phys 2008;70:51-8.
• 54 Mumbrekar KD, Fernandes DJ, Goutham HV, Sharan K, Vadhiraja BM, Satyamoorthy K, et al. Influence of double-strand break repair on radiation therapy-induced acute skin reactions in breast cancer patients. Int J Radiat Oncol Biol Phys 2014;88:671-6.
• 55 Munshi A, Wadasadawala T, Sharma PK, Sharma D, Budrukkar A, Jalali R, et al. Radiation therapy planning of a breast cancer patient with in situ pacemaker - Challenges and lessons. Acta Oncol 2008;47:255-60.
• 56 Chakrabarty J, Vidyasagar M, Fernandes D, Joisa G, Varghese P, Mayya S. Effectiveness of pranayama on cancer-related fatigue in breast cancer patients undergoing radiation therapy: A randomized controlled trial. Int J Yoga 2015;8:47-53.